Jpmorgan Chase & CO Liquidia Corp Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Liquidia Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 28,205 shares of LQDA stock, worth $454,382. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,205
Previous 235,393 88.02%
Holding current value
$454,382
Previous $2.35 Million 85.93%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$9.82 - $11.8 $2.03 Million - $2.44 Million
-207,188 Reduced 88.02%
28,205 $331,000
Q3 2024

Dec 26, 2024
BUY
$8.9 - $14.11 $1.88 Million - $2.97 Million
210,753 Added 855.33%
235,393 $2.35 Million
Q3 2024

Nov 08, 2024
BUY
$8.9 - $14.11 $1.88 Million - $2.97 Million
210,753 Added 855.33%
235,393 $2.35 Million
Q2 2024

Dec 26, 2024
SELL
$11.96 - $15.71 $2.52 Million - $3.31 Million
-210,753 Reduced 89.53%
24,640 $295,000
Q2 2024

Aug 12, 2024
BUY
$11.96 - $15.71 $60,386 - $79,319
5,049 Added 25.77%
24,640 $295,000
Q1 2024

Dec 26, 2024
SELL
$11.35 - $16.73 $2.45 Million - $3.61 Million
-215,802 Reduced 91.68%
19,591 $288,000
Q1 2024

May 10, 2024
SELL
$11.35 - $16.73 $134,054 - $197,598
-11,811 Reduced 37.61%
19,591 $288,000
Q4 2023

Dec 26, 2024
SELL
$5.77 - $12.19 $1.18 Million - $2.49 Million
-203,991 Reduced 86.66%
31,402 $377,000
Q4 2023

Feb 12, 2024
SELL
$5.77 - $12.19 $4,679 - $9,886
-811 Reduced 2.52%
31,402 $377,000
Q3 2023

Nov 14, 2023
SELL
$6.27 - $8.15 $28,779 - $37,408
-4,590 Reduced 12.47%
32,213 $204,000
Q2 2023

Aug 11, 2023
SELL
$6.63 - $9.9 $3,653 - $5,454
-551 Reduced 1.48%
36,803 $288,000
Q1 2023

May 18, 2023
BUY
$5.72 - $7.91 $209,117 - $289,181
36,559 Added 4598.62%
37,354 $258,000
Q1 2023

May 11, 2023
SELL
$5.72 - $7.91 $155,172 - $214,582
-27,128 Reduced 97.15%
795 $5,000
Q4 2022

Feb 13, 2023
BUY
$4.68 - $6.54 $8,634 - $12,066
1,845 Added 7.07%
27,923 $178,000
Q3 2022

Nov 14, 2022
BUY
$3.73 - $8.39 $2,099 - $4,723
563 Added 2.21%
26,078 $142,000
Q2 2022

Aug 11, 2022
BUY
$3.37 - $7.55 $85,985 - $192,638
25,515 New
25,515 $111,000

Others Institutions Holding LQDA

# of Institutions
188
Shares Held
44.8M
Call Options Held
1.22M
Put Options Held
1.09M
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.04B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email